Key Highlights
- 49.7% was the October 15, 2026 gain for Exascale Labs (NASDAQ:XLAB), from USD 0.909 to USD 1.36, own arithmetic on two closes. The 8-K signed that day disclosed a USD 8.208 million agreement to supply 12 NVIDIA HGX B300 servers with 96 GPUs.
- USD 14 million of revenue is what the SEC alleges Netcapital (NASDAQ:NCPL) improperly recorded, per a complaint filed in August 2026. These are allegations, not findings. A Nasdaq compliance plan over the unfiled annual report is due October 23, 2026.
- USD 50 million is the equity line expanded in 2026 by Reliance Global Group (NASDAQ:EZRA), 12.0 times its USD 4.17 million market value, own arithmetic. Shares rose 14.81% to USD 2.48 on relative volume of 0.29, with no catalyst identified.
- 98.95% of the 3,998,108 public shares of RF Acquisition Corp II (NASDAQ:RFAI) were subject to preliminary redemption requests after the August 19, 2026 vote, own arithmetic. The trust held USD 44.52 million after August 12 redemptions, USD 11.14 per remaining share.
Exascale Labs (NASDAQ:XLAB)
Exascale entered a Purchase and Sale Agreement on October 8, 2026 with Sunon Inc., a California subsidiary of a Taiwan-listed parent, per the 8-K signed October 15. The USD 8.208 million package covers 12 servers, networking, deployment and 36 months of IT operation services, excluding duties and taxes, equal to 55% of fiscal 2026 revenue of USD 14.82 million (own arithmetic). A 30% down payment is due within 3 days of the buyer's purchase order. The 8-K states no link to the share price. Volume of 16.2 million shares was USD 22.0 million of turnover, 17.8% of a USD 124 million market value (own arithmetic); a second data set shows USD 63.99 million on a different share basis. Exascale Labs (NASDAQ:XLAB) closed its SPAC combination with D. Boral ARC Acquisition I Corp. on August 27, 2026. Net loss was USD 12.16 million. Delivery depends on chip manufacturer approval and export and import authorizations. A July 16 commitment to procure USD 71.4 million of compute has no disclosed financing, warrants at USD 11.50 remain outstanding, and the USD 300 million pipeline was described as prospective opportunities, not backlog.
Netcapital (NASDAQ:NCPL)
The SEC complaint, filed in federal court in Boston in August 2026, alleges sham consulting revenue tied to adviser John Fanning and forged offering documents; the company and its chief financial officer are named. Netcapital received a Wells notice in March 2026. Nasdaq issued a delinquency notice on August 24 for the late Form 10-K for the year ended April 30, 2026. A plan is due October 23, and an accepted plan may extend the deadline to February 9, 2027. A separate bid-price notice dated February 4 carries a cure date of February 1, 2027, after a 1-for-70 reverse split in July 2024. Preliminary fiscal 2026 revenue was USD 460,883, down 47%, against a net loss of USD 9.23 million. Published data show USD 2.31, up 16.66%, on 12.13 million shares, USD 28.0 million of turnover or 154% of the USD 18.13 million market value (own arithmetic). Volume exceeds the implied 7.85 million shares, so the data set is inconsistent. No catalyst was identified. Cash and going-concern language are not disclosed in the filings reviewed.
Reliance Global Group (NASDAQ:EZRA)
Reliance is an insurance agency business that effected a 1-for-40 reverse split on May 18, 2026, cutting shares from 22.23 million to 555,764, and Nasdaq confirmed bid price compliance on June 3. An equity line lets a company sell shares to an investor at a discount in tranches it chooses, so each draw adds shares. Reliance Global Group (NASDAQ:EZRA) also sold 278,978 shares through an at-the-market program for USD 1.12 million and raised USD 2.53 million in a Series K offering with warrants. The share count reached 1,002,998 on July 30, 2026. Second quarter commission income fell 31.7% to USD 2.11 million, with a net loss of USD 1.99 million. Cash and restricted cash were USD 1.81 million at June 30, of which USD 843,513 was unrestricted, which covers 1.3 months of net loss (own arithmetic). Management states there is no substantial doubt over its ability to continue as a going concern. Turnover of USD 593,340 on 239,250 shares was 14.2% of market value (own arithmetic). Nasdaq rules restrict another reverse split within one year.
RF Acquisition Corp II (NASDAQ:RFAI)
A special purpose acquisition company is a listed shell that raises cash in an IPO to buy a private business. On August 12, 2026 holders approved an extension to as late as February 15, 2027, with USD 75,000 monthly sponsor deposits. On August 19 they approved a merger with Singapore-based Nanyang Biologics, reported at USD 1.5 billion and not independently confirmed. Redemptions let holders take a pro rata share of the trust, so each one shrinks the cash left for the deal. Trust assets fell 63.8% from USD 122.87 million on September 30, 2025 to USD 44.52 million (own arithmetic). If the requests stand, 41,785 public shares remain (own arithmetic), and requests can still be withdrawn. An amended registration covers up to 158,940,640 new shares of RF Acquisition Corp II (NASDAQ:RFAI). The 10-Q for the quarter ended June 30, 2026 flags going-concern doubt and a material weakness. The USD 34.00 quote on 10,330 shares is 3.05 times trust value per share (own arithmetic) and is not a reliable valuation.
Where Things Stand
Netcapital (NASDAQ:NCPL) carries the heaviest regulatory risk, while RF Acquisition carries the heaviest dilution exposure. Ranked by largest disclosed exposure divided by market value or share base (own arithmetic): RF Acquisition 19.0x on registered new shares, Reliance 12.0x on the equity line, Netcapital 0.77x on alleged revenue, Exascale 0.58x on the compute commitment. Reliance Global Group (NASDAQ:EZRA) rose on quiet volume with no catalyst. Exascale Labs (NASDAQ:XLAB) holds a conditional order. Next dated events: the Netcapital plan on October 23, 2026, the Sunon purchase order and RFAI registration effectiveness.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...